Protease inhibitor

A cross-sectional study to evaluate the association of hyperbilirubinaemia on markers of cardiovascular disease, neurocognitive function, bone mineral density and renal markers in HIV-1 infected subjects on protease inhibitors.

Authors: T. J. Barber, G. Moyle, A. Hill, G. Jagjit Singh, A. Scourfield, H. M. Yapa, L. Waters, D. Asboe, M. Boffito, M. Nelson

Journal: HIV Clinical Trials

Year Published: 2016

Background: Ongoing inflammation in controlled HIV infection contributes to non-AIDS comorbidities. High bilirubin appears to exhibit an anti-inflammatory effect in vivo. We therefore examined whether increased bilirubin in persons with HIV was associated with differences in […]

Back to Publications